Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action

McFarland JM, Paolella BR, Warren A, Geiger-Schuller K, Shibue T, Rothberg M, Kuksenko O, Colgan WN, Jones A, Chambers E, et al. Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action. Nat Commun. 2020;11:4296.
NOTES

McFarland, James MPaolella, Brenton RWarren, AllisonGeiger-Schuller, KathrynShibue, TsukasaRothberg, MichaelKuksenko, OlenaColgan, William NJones, AndrewChambers, EmilyDionne, DanielleBender, SamanthaWolpin, Brian MGhandi, MahmoudTirosh, ItayRozenblatt-Rosen, OritRoth, Jennifer AGolub, Todd RRegev, AvivAguirre, Andrew JVazquez, FranciscaTsherniak, AviadengK08 CA218420/CA/NCI NIH HHS/P50 CA127003/CA/NCI NIH HHS/U01 CA224146/CA/NCI NIH HHS/HHMI/Howard Hughes Medical Institute/Research Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tEnglandNat Commun. 2020 Aug 27;11(1):4296. doi: 10.1038/s41467-020-17440-w.

Last updated on 05/10/2021